Fdabaa -20-00123 robust in vitro/in silico model to accelerate generic drug product development for the oral cavity route of administration
Ended Definitive Contract Awarded Last action
- Contract number
- 75F40120C00150
- Awardee
-
University Of Health Sciences And Pharmacy In ST. Louis UEI NMMKG6CCEMW4
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $1,158,640
Award facts
- Opportunity
-
- Food and Drug Administration Broad Agency Announcement (BAA) for the Advanced Research and Development of Regulatory Science - Amendment 2 Solicitation · FDABAA2000123 · Posted Sep 27, 2019
- Contract value 100% obligated
- $1,158,639.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 34 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- St. Louis, MO 63110, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$2 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Novation Agreement | $0 | |
| Original award | $1,158,642 |
About this award
The Food and Drug Administration awarded a definitive contract to University Of Health Sciences And Pharmacy In ST. Louis on September 28, 2020, with a ceiling value of $1,158,639.76 for development of a robust in vitro/in silico model to accelerate generic drug product development for the oral cavity route of administration. The contract was cost no fee and completed on June 29, 2025.
The originating solicitation, posted September 27, 2019, under the FDA's Broad Agency Announcement for Advanced Research and Development of Regulatory Science, sought proposals across nine regulatory science areas evaluated on technical merit, offeror qualifications, and cost reasonableness. Multiple awards of indefinite quantities and values were anticipated. Work is classified under NAICS 541715 (research and development in the physical, engineering, and life sciences) and PSC R425 (biomedical research and development).
Place of performance is St. Louis, MO. In fiscal 2021, the contract invoiced $349 thousand against 1.2 FTEs and 2,445 contractor hours at a blended derived rate of $142.59 per hour, with one subcontractor performing 17 percent of contractor hours.
Quick answers
Who was awarded contract 75F40120C00150?
75F40120C00150 was awarded to University Of Health Sciences And Pharmacy In ST. Louis by Food and Drug Administration (Department of Health and Human Services) on September 28, 2020.
How much is contract 75F40120C00150 worth?
The government has obligated $1,158,640 on 75F40120C00150.
Was contract 75F40120C00150 competed?
The extent of competition for 75F40120C00150 was full and open competition. The government received 34 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award